Trials / Unknown
UnknownNCT04009772
Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic During Emergency Intrapartum Cesarean Section
Single Dose Cefepime Versus Cefuroxime Plus Metronidazole as a Prophylactic Antibiotic: A Randomized Controlled Study
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 500 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Compare between cefepime versus routine antibiotics as a prophylactic antibiotic during emergency cesarean section in a tertiary center of obstetric care
Detailed description
This is a randomized double blinded study which compare between single dose cefepime versus cefuroxime plus metronidazole during emergency intrapartum cesarean section. Outcomes will include fever, wound infection, and urinary tract infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Cefepime | Antibiotic prophylaxis |
| DRUG | Cefuroxime plus Metronidazole | Antibiotic prophylaxis |
Timeline
- Start date
- 2019-07-01
- Primary completion
- 2020-02-01
- Completion
- 2020-03-01
- First posted
- 2019-07-05
- Last updated
- 2019-07-05
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04009772. Inclusion in this directory is not an endorsement.